Kerala Ayurveda Ltd
Kerala Ayurveda Ltd (KERALAYUR) last reported results for the quarter ended Jun 2026, with sales of ₹33.19 crore and net profit of ₹-8.08 crore. The stock last traded at ₹146, a market capitalisation of ₹189 crore. Over the past 52 weeks the stock has ranged between ₹141 and ₹471. Figures are as of 6 Oct 2026 and are not real time.
Kerala Ayurveda Ltd share price and key metrics
- Current price
- ₹146
- Market cap
- ₹189 cr
- Book value
- ₹8.56
- ROE
- -161%
- ROCE
- -9.77%
- Dividend yield
- 0.00%
- 52w high / low
- 471/141
Metrics as of 6 Oct 2026. Not real time.
Track Kerala Ayurveda Ltd
Cruxal reads every Kerala Ayurveda Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Kerala Ayurveda Ltd growth and returns
- 10 Years
- 11%
- 5 Years
- 16%
- 3 Years
- 12%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -104%
- 10 Years
- 8%
- 5 Years
- 19%
- 3 Years
- -4%
- 1 Year
- -68%
- 10 Years
- -36%
- 5 Years
- -69%
- 3 Years
- -85%
- Last Year
- -161%
Kerala Ayurveda Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹33.19 cr, up 16.0% from ₹28.61 cr a year earlier. Net profit swung to a loss of ₹8.08 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 30.41 | 31.13 | 31.32 | 28.61 | 34.84 | 32.96 | 34.74 | 33.19 |
| Expenses | 24.88 | 32.32 | 41.46 | 32.8 | 39.79 | 34.47 | 41.84 | 37.02 |
| Operating profit | 5.53 | -1.19 | -10.14 | -4.19 | -4.95 | -1.51 | -7.1 | -3.83 |
| OPM % | 18.18% | -3.82% | -32.38% | -14.65% | -14.21% | -4.58% | -20.44% | -11.54% |
| Other income | 0.64 | 0.23 | 0.73 | 9.47 | 1.7 | 1.13 | 1.91 | 0.26 |
| Interest | 0.72 | 0.43 | 2.48 | 0.82 | 2.58 | 2.84 | 1.1 | 2.79 |
| Depreciation | 1.98 | 0.72 | 1.92 | 1.65 | 0.99 | 1.15 | 1.69 | 1.87 |
| Profit before tax | 3.47 | -2.11 | -13.81 | 2.81 | -6.82 | -4.37 | -7.98 | -8.23 |
| Tax % | -4.90% | 27.96% | 11.30% | 27.76% | -6.74% | 5.26% | -7.39% | -1.82% |
| Net profit | 3.65 | -2.7 | -15.38 | 2.03 | -6.36 | -4.6 | -7.39 | -8.08 |
| EPS (₹) | 2.84 | -2.40 | -12.92 | 1.65 | -5.26 | -3.69 | -5.97 | -6.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Kerala Ayurveda Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 50 | 59 | 59 | 77 | 62 | 80 | 93 | 108 | 126 | 131 | 136 |
| Operating profit | 7 | 8 | 5 | 7 | 1 | 10 | 3 | 9 | -5 | -18 | -17 |
| OPM % | 14% | 14% | 9% | 10% | 1.4% | 12% | 2.8% | 8% | -4.0% | -14% | -13% |
| Net profit | 3 | 3 | 3 | 4 | -5 | 2 | -0 | -1 | -14 | -16 | -26 |
| EPS (₹) | 2.90 | 2.66 | 2.31 | 3.69 | -4.59 | 2.24 | -0.85 | -0.47 | -11.60 | -12.74 | -21.06 |
TTM is the trailing twelve months to the most recent quarter.
Kerala Ayurveda Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 13 |
| Reserves | -4 | -3 | -7 | -3 | -7 | -4 | -5 | 7 | -3 | -2 |
| Borrowings | 56 | 75 | 62 | 64 | 77 | 70 | 72 | 76 | 71 | 86 |
| Other liabilities | 17 | 20 | 27 | 31 | 34 | 34 | 37 | 38 | 49 | 41 |
| Total liabilities | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 133 | 129 | 138 |
| Fixed assets | 34 | 32 | 33 | 33 | 33 | 44 | 46 | 41 | 47 | 50 |
| CWIP | 6 | 11 | 12 | 14 | 14 | 4 | 7 | 7 | 9 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 41 | 59 | 47 | 56 | 68 | 62 | 61 | 85 | 73 | 81 |
| Total assets | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 133 | 129 | 138 |
As reported by the company. Total assets equal total liabilities by construction.
Kerala Ayurveda Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | -10 | 12 | 5 | 7 | -0 | 10 | -1 | 5 | -24 |
| Cash from investing | -3 | -3 | -3 | -4 | -1 | -2 | -7 | -0 | -15 | -5 |
| Cash from financing | 0 | 17 | -12 | 1 | 6 | -13 | -2 | 20 | -9 | 32 |
| Net cash flow | 1 | 4 | -2 | 2 | 12 | -16 | 0 | 18 | -19 | 3 |
| Free cash flow | 3 | -16 | 10 | 2 | 6 | -3 | 4 | -2 | -8 | -30 |
| CFO / operating profit | 62% | -120% | 251% | 71% | 885% | -5% | 390% | 1% | -138% | 136% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Kerala Ayurveda Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 9% | 9% | 6% | 9% | -0% | 11% | 2% | 8% | -9% | -10% |
| Debtor days | 35 | 34 | 43 | 51 | 61 | 61 | 51 | 59 | 56 | 38 |
| Inventory days | 319 | 338 | 311 | 313 | 268 | 254 | 227 | 205 | 208 | 200 |
| Days payable | 112 | 125 | 117 | 162 | 149 | 168 | 137 | 114 | 93 | 129 |
| Cash conversion cycle | 242 | 247 | 236 | 202 | 179 | 147 | 141 | 149 | 171 | 109 |
| Working capital days | -213 | -63 | -24 | -19 | -99 | -118 | -81 | -172 | -147 | -162 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Kerala Ayurveda Ltd shareholding pattern
Promoters held 35.60% at Jun 2026, down from 37.83% at Jun 2025. FIIs 0.17% and DIIs 0.03%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 58.58% | 58.58% | 58.58% | 37.83% | 33.14% | 33.14% | 35.60% | 35.60% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.22% | 0.17% | 0.17% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 41.38% | 41.37% | 41.37% | 62.12% | 66.81% | 66.59% | 64.20% | 64.18% |
| No. of shareholders | 9,052 | 9,009 | 9,074 | 9,401 | 9,938 | 9,952 | 10,225 | 10,372 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Kerala Ayurveda Ltd corporate filings
- Compliances-Certificate under Reg-74(5) of SEBI (DP) Regulations,2018Company Updatelow impact
- Kerala Ayurveda Limited's AGM Voting Results Confirm Shareholder Approval of Key ResolutionsAGM/EGMhigh impact
Cruxal's analysis: Kerala Ayurveda Limited held its 34th AGM on September 28, 2026, with all resolutions…
Read the full analysis - Kerala Ayurveda Limited Proposes Preferential Issue of 6.55 Lakh Equity Shares to Promoter Group for Debt ReductionCompany Updatemedium impact
Cruxal's analysis: Kerala Ayurveda Limited has announced the proceedings of its 34th Annual General Meeting…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Kerala Ayurveda Ltd publishes routine newspaper notice regarding corporate disclosureCompany Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has completed a routine newspaper publication as part of its…
Read the full analysis - Kerala Ayurveda Limited Announces Corrigendum to Preferential Issue of 6.55 Lakh Equity Shares to Promoter GroupCompany Updatemedium impact
Cruxal's analysis: Kerala Ayurveda Limited has issued a corrigendum to its 34th Annual General Meeting…
Read the full analysis - Kerala Ayurveda Ltd publishes newspaper advertisement regarding dispatch of Annual ReportCompany Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has published a mandatory newspaper advertisement confirming the…
Read the full analysis - Kerala Ayurveda Limited Announces 34th AGM and Preferential Issue of Equity Shares to Promoter GroupAGM/EGMmedium impact
Cruxal's analysis: Kerala Ayurveda Limited has scheduled its 34th Annual General Meeting for September 28…
Read the full analysis - Kerala Ayurveda Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Kerala Ayurveda Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Kerala Ayurveda Ltd: Routine newspaper publication of financial results noticeCompany Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has fulfilled its regulatory obligation under Regulation 30 of the…
Read the full analysis - Kerala Ayurveda Limited Announces Preferential Allotment of 7.20 Lakh Equity Shares to Promoter Group for Debt ReductionCompany Updatemedium impact
Cruxal's analysis: Kerala Ayurveda Limited has approved a preferential issue of 7.20 lakh equity shares at a…
Read the full analysis - Kerala Ayurveda Limited Announces Board Meeting to Consider Preferential Issue of Equity SharesBoard Meetinghigh impact
Cruxal's analysis: Kerala Ayurveda Limited has scheduled a Board meeting for September 04, 2026, to evaluate…
Read the full analysis - Kerala Ayurveda Ltd: Newspaper publication of financial results noticeCompany Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has fulfilled its regulatory obligation under Regulation 30 of the…
Read the full analysis - Kerala Ayurveda Ltd files routine press release under Regulation 30Company Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has submitted a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Kerala Ayurveda Ltd announces allotment of equity shares under ESOP schemeCompany Updatelow impact
Cruxal's analysis: Kerala Ayurveda Ltd has formally announced the allotment of equity shares pursuant to the…
Read the full analysis - Kerala Ayurveda Limited Reports Q1 FY2027 Financial Results, Announces Amalgamation of Wholly Owned Subsidiary and ESOP GrantBoard Meetingmedium impact
Cruxal's analysis: Kerala Ayurveda Limited reported a net loss of 7.67 crore for the quarter ended June 30…
Read the full analysis - Kerala Ayurveda Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Kerala Ayurveda Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.